Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer

Majd Agbaria, Doaa Jbara-Agbaria, Etty Grad, Meital Ben-David-Naim, Gil Aizik, Gershon Golomb

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases